Home MacuLogix: Dark Adaptation and AMD Maculogix Announces PCO/Salus Endowment for AMD Advocacy

Maculogix Announces PCO/Salus Endowment for AMD Advocacy

MacuLogix has established a $25,000 MacuLogix AMD Advocacy endowed award at Salus University Pennsylvania College of Optometry. PCU/Salus University was chosen for this award to honor two of its graduates, Glenn S. Corbin, OD, of Wyomissing Optometric Center in Wyomissing, Pennsylvania, and Gary Kirman, OD, of Kirman Eye in Hummelstown, Pennsylvania, for their commitment to AMD diagnosis.

“PCO/Salus is proud of our alumni in bringing AdaptDx Pro to their patients to assess AMD.
We are thrilled to receive these funds to create an award for AMD advocacy and eager to
share the technology with our students as they deliver patient care” says Melissa Trego, OD, PhD, Dean of PCO.

(l.-r.) Victoria Dzurinko, OD; Gary Kirman, OD; Glenn Corbin, OD; Greg Jackson, PhD; Dave Miller; Melissa Trego, OD, PhD; Michael Mittelman, OD, MPH, MBA, FAAO, FACHE

As the first commercial customers of MacuLogix, Drs. Corbin and Kirman have been utilizing dark adaptation testing in their practices since 2014, starting with the original AdaptDx® automated dark adaptometer. In 2020, they also became the first optometrists to use the AdaptDx Pro® head-mounted dark adaptometer.

“After seeing the devastating effects of AMD on several of my family and
friends, finding and treating this disease has been my passion and my purpose. After
performing nearly 4,000 dark adaptation tests in seven years, we are extremely confident that we are finding and treating every patient in our practice with AMD,” says Dr. Kirman.

“The past seven years of using dark adaptation testing in my practice has completely changed my outlook on this devastating disease,” says Dr. Corbin. “Gary and I are both very humbled and honored to have MacuLogix provide our alma mater with this generous endowment to inspire the next generation of optometrists to focus on detecting and treating AMD with the goal of preserving their patients’ vision.”

“Glenn and Gary have been instrumental in our success by elevating the standard of care for AMD patients,” says Gregory R. Jackson, PhD, co-founder and Chief Technology Officer of MacuLogix. “From day one, they have been committed to sharing their knowledge and real-world experience with MacuLogix. We are excited to honor them with this award to PCO to inspire future doctors to be as passionate about AMD care as they are.”

MacuLogix is also donating an AdaptDx Pro to the PCO clinic in Chestnut Hill, Pennsylvania, to provide fourth-year optometry students an opportunity to utilize the latest technology before transitioning to practice.

- Advertisment -

Most Popular

Dr. Caitlin Reghetti: Supporting Patient Education With a Great Design

On her LinkedIn page, Caitlin Reghetti, OD, calls herself an ocular health literacy designer. It's a specialized role that brings together her interests in...

WO Board Perspectives: How to Stay Organized

In a world where we all wear many hats-- doctor, parent, spouse, child, friend, mentor and more-- staying organized can feel nearly impossible. The...

Advocates for Optometry on Capitol Hill

More than 500 optometrists and students gathered for the American Optometric Association’s AOA on the Hill on April 15 and 16 to advocate for...

Myopia Awareness Week 2024 Website Launches

Myopia Awareness Week 2024 is set for May 13-19, and Review of Myopia Management and BHVI have officially launched the website for the week-long...